nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—ABCC5—Fluorouracil—colon cancer	0.142	0.189	CbGbCtD
Dinoprostone—SLCO3A1—Methotrexate—colon cancer	0.123	0.163	CbGbCtD
Dinoprostone—SLCO1C1—Methotrexate—colon cancer	0.0786	0.104	CbGbCtD
Dinoprostone—SLC22A7—Fluorouracil—colon cancer	0.07	0.0927	CbGbCtD
Dinoprostone—ABCC4—Fluorouracil—colon cancer	0.0684	0.0906	CbGbCtD
Dinoprostone—SLCO1B1—Irinotecan—colon cancer	0.0483	0.0639	CbGbCtD
Dinoprostone—SLC22A11—Methotrexate—colon cancer	0.0405	0.0537	CbGbCtD
Dinoprostone—SLC22A7—Methotrexate—colon cancer	0.0386	0.0511	CbGbCtD
Dinoprostone—ABCC4—Methotrexate—colon cancer	0.0377	0.05	CbGbCtD
Dinoprostone—SLCO1A2—Methotrexate—colon cancer	0.0271	0.0359	CbGbCtD
Dinoprostone—SLCO1B1—Methotrexate—colon cancer	0.0255	0.0338	CbGbCtD
Dinoprostone—SLC22A8—Methotrexate—colon cancer	0.0236	0.0312	CbGbCtD
Dinoprostone—SLC22A6—Methotrexate—colon cancer	0.0164	0.0218	CbGbCtD
Dinoprostone—CYP1A2—Fluorouracil—colon cancer	0.0152	0.0201	CbGbCtD
Dinoprostone—Vaginal pain—Capecitabine—colon cancer	0.00505	0.0638	CcSEcCtD
Dinoprostone—Vulvovaginal pain—Capecitabine—colon cancer	0.00505	0.0638	CcSEcCtD
Dinoprostone—PTGIR—endothelium—colon cancer	0.00327	0.0313	CbGeAlD
Dinoprostone—PTGIR—blood vessel—colon cancer	0.00302	0.0288	CbGeAlD
Dinoprostone—SLC51B—digestive system—colon cancer	0.00257	0.0245	CbGeAlD
Dinoprostone—PTGER4—epithelium—colon cancer	0.00246	0.0235	CbGeAlD
Dinoprostone—PTGER4—smooth muscle tissue—colon cancer	0.00237	0.0227	CbGeAlD
Dinoprostone—PTGER4—renal system—colon cancer	0.00228	0.0218	CbGeAlD
Dinoprostone—HPGDS—embryo—colon cancer	0.00221	0.0211	CbGeAlD
Dinoprostone—PTGER1—renal system—colon cancer	0.00221	0.0211	CbGeAlD
Dinoprostone—PTGER3—smooth muscle tissue—colon cancer	0.00201	0.0192	CbGeAlD
Dinoprostone—PTGER3—renal system—colon cancer	0.00193	0.0185	CbGeAlD
Dinoprostone—SLC51B—liver—colon cancer	0.00191	0.0183	CbGeAlD
Dinoprostone—PTGER4—lymphoid tissue—colon cancer	0.0019	0.0181	CbGeAlD
Dinoprostone—PTGER4—digestive system—colon cancer	0.00187	0.0179	CbGeAlD
Dinoprostone—SLC51A—digestive system—colon cancer	0.00184	0.0176	CbGeAlD
Dinoprostone—Shivering—Capecitabine—colon cancer	0.00183	0.0232	CcSEcCtD
Dinoprostone—HPGDS—epithelium—colon cancer	0.0018	0.0172	CbGeAlD
Dinoprostone—PTGER2—bone marrow—colon cancer	0.00176	0.0168	CbGeAlD
Dinoprostone—PTGER2—vagina—colon cancer	0.00169	0.0161	CbGeAlD
Dinoprostone—HPGDS—renal system—colon cancer	0.00167	0.016	CbGeAlD
Dinoprostone—SLC51A—vagina—colon cancer	0.00163	0.0155	CbGeAlD
Dinoprostone—PTGFR—smooth muscle tissue—colon cancer	0.00161	0.0154	CbGeAlD
Dinoprostone—PTGER3—digestive system—colon cancer	0.00159	0.0152	CbGeAlD
Dinoprostone—PTGIR—epithelium—colon cancer	0.00147	0.014	CbGeAlD
Dinoprostone—Chest tightness—Capecitabine—colon cancer	0.00146	0.0184	CcSEcCtD
Dinoprostone—PTGIR—smooth muscle tissue—colon cancer	0.00142	0.0135	CbGeAlD
Dinoprostone—HPGDS—lymphoid tissue—colon cancer	0.00139	0.0133	CbGeAlD
Dinoprostone—HPGDS—digestive system—colon cancer	0.00137	0.0131	CbGeAlD
Dinoprostone—SLC51A—liver—colon cancer	0.00137	0.0131	CbGeAlD
Dinoprostone—SLCO1C1—renal system—colon cancer	0.00137	0.0131	CbGeAlD
Dinoprostone—PTGIR—renal system—colon cancer	0.00136	0.013	CbGeAlD
Dinoprostone—SLC22A11—renal system—colon cancer	0.00133	0.0127	CbGeAlD
Dinoprostone—SLC22A7—renal system—colon cancer	0.0013	0.0124	CbGeAlD
Dinoprostone—SLCO2A1—epithelium—colon cancer	0.00128	0.0123	CbGeAlD
Dinoprostone—HPGDS—bone marrow—colon cancer	0.00126	0.0121	CbGeAlD
Dinoprostone—HPGDS—vagina—colon cancer	0.00121	0.0116	CbGeAlD
Dinoprostone—SLCO3A1—renal system—colon cancer	0.0012	0.0115	CbGeAlD
Dinoprostone—SLCO2A1—renal system—colon cancer	0.00119	0.0114	CbGeAlD
Dinoprostone—SLC22A2—renal system—colon cancer	0.00115	0.011	CbGeAlD
Dinoprostone—PTGIR—digestive system—colon cancer	0.00112	0.0107	CbGeAlD
Dinoprostone—SLCO4A1—renal system—colon cancer	0.0011	0.0105	CbGeAlD
Dinoprostone—PTGER2—lymph node—colon cancer	0.00109	0.0104	CbGeAlD
Dinoprostone—SLC22A11—digestive system—colon cancer	0.00109	0.0104	CbGeAlD
Dinoprostone—PTGER4—lymph node—colon cancer	0.00107	0.0102	CbGeAlD
Dinoprostone—Neck stiffness—Methotrexate—colon cancer	0.00107	0.0135	CcSEcCtD
Dinoprostone—SLC22A7—digestive system—colon cancer	0.00106	0.0102	CbGeAlD
Dinoprostone—SLC51A—lymph node—colon cancer	0.00105	0.01	CbGeAlD
Dinoprostone—HPGDS—liver—colon cancer	0.00102	0.00976	CbGeAlD
Dinoprostone—Hiccups—Irinotecan—colon cancer	0.00102	0.0129	CcSEcCtD
Dinoprostone—Inflammation—Fluorouracil—colon cancer	0.00101	0.0127	CcSEcCtD
Dinoprostone—Nuchal rigidity—Methotrexate—colon cancer	0.000981	0.0124	CcSEcCtD
Dinoprostone—SLCO1B1—renal system—colon cancer	0.000965	0.00921	CbGeAlD
Dinoprostone—Laryngitis—Capecitabine—colon cancer	0.000948	0.012	CcSEcCtD
Dinoprostone—SLC22A2—digestive system—colon cancer	0.000947	0.00904	CbGeAlD
Dinoprostone—PTGFR—liver—colon cancer	0.000945	0.00903	CbGeAlD
Dinoprostone—PTGER3—lymph node—colon cancer	0.000907	0.00866	CbGeAlD
Dinoprostone—SLCO4A1—digestive system—colon cancer	0.000899	0.00859	CbGeAlD
Dinoprostone—SLCO3A1—vagina—colon cancer	0.000871	0.00832	CbGeAlD
Dinoprostone—SLCO2A1—vagina—colon cancer	0.000863	0.00825	CbGeAlD
Dinoprostone—SLCO2B1—renal system—colon cancer	0.000853	0.00815	CbGeAlD
Dinoprostone—Deafness—Vincristine—colon cancer	0.000851	0.0107	CcSEcCtD
Dinoprostone—PTGIR—liver—colon cancer	0.000833	0.00796	CbGeAlD
Dinoprostone—ABCC5—bone marrow—colon cancer	0.000824	0.00787	CbGeAlD
Dinoprostone—SLC22A1—renal system—colon cancer	0.000815	0.00779	CbGeAlD
Dinoprostone—SLC22A11—liver—colon cancer	0.000812	0.00776	CbGeAlD
Dinoprostone—SLCO4A1—vagina—colon cancer	0.000794	0.00758	CbGeAlD
Dinoprostone—SLC22A7—liver—colon cancer	0.000792	0.00757	CbGeAlD
Dinoprostone—SLCO1B1—digestive system—colon cancer	0.000791	0.00756	CbGeAlD
Dinoprostone—ABCC5—vagina—colon cancer	0.000789	0.00754	CbGeAlD
Dinoprostone—SLCO1A2—renal system—colon cancer	0.000785	0.0075	CbGeAlD
Dinoprostone—HPGDS—lymph node—colon cancer	0.000783	0.00748	CbGeAlD
Dinoprostone—Chest discomfort—Capecitabine—colon cancer	0.000773	0.00975	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Irinotecan—colon cancer	0.000766	0.00967	CcSEcCtD
Dinoprostone—Musculoskeletal stiffness—Capecitabine—colon cancer	0.000762	0.00962	CcSEcCtD
Dinoprostone—Skin discolouration—Capecitabine—colon cancer	0.000757	0.00955	CcSEcCtD
Dinoprostone—ABCC4—renal system—colon cancer	0.000755	0.00722	CbGeAlD
Dinoprostone—SLC22A8—renal system—colon cancer	0.000749	0.00716	CbGeAlD
Dinoprostone—SLCO3A1—liver—colon cancer	0.000735	0.00702	CbGeAlD
Dinoprostone—SLCO2A1—liver—colon cancer	0.000728	0.00696	CbGeAlD
Dinoprostone—PTGFR—lymph node—colon cancer	0.000725	0.00692	CbGeAlD
Dinoprostone—Urinary retention—Vincristine—colon cancer	0.000724	0.00914	CcSEcCtD
Dinoprostone—Cardiac arrest—Vincristine—colon cancer	0.000724	0.00914	CcSEcCtD
Dinoprostone—Hearing impaired—Capecitabine—colon cancer	0.000718	0.00907	CcSEcCtD
Dinoprostone—Dehydration—Vincristine—colon cancer	0.000708	0.00894	CcSEcCtD
Dinoprostone—Cardiac arrest—Irinotecan—colon cancer	0.000705	0.0089	CcSEcCtD
Dinoprostone—Inflammation—Capecitabine—colon cancer	0.000705	0.0089	CcSEcCtD
Dinoprostone—SLCO2B1—digestive system—colon cancer	0.0007	0.00668	CbGeAlD
Dinoprostone—Dehydration—Irinotecan—colon cancer	0.000689	0.0087	CcSEcCtD
Dinoprostone—Hiccups—Capecitabine—colon cancer	0.000684	0.00863	CcSEcCtD
Dinoprostone—Cardiac arrest—Fluorouracil—colon cancer	0.000675	0.00852	CcSEcCtD
Dinoprostone—SLCO4A1—liver—colon cancer	0.00067	0.0064	CbGeAlD
Dinoprostone—Cramp muscle—Irinotecan—colon cancer	0.000668	0.00843	CcSEcCtD
Dinoprostone—ABCC5—liver—colon cancer	0.000666	0.00636	CbGeAlD
Dinoprostone—SLCO1A2—digestive system—colon cancer	0.000644	0.00615	CbGeAlD
Dinoprostone—SLCO1C1—lymph node—colon cancer	0.000641	0.00612	CbGeAlD
Dinoprostone—PTGIR—lymph node—colon cancer	0.000639	0.0061	CbGeAlD
Dinoprostone—Sweating increased—Irinotecan—colon cancer	0.000624	0.00788	CcSEcCtD
Dinoprostone—ABCC4—digestive system—colon cancer	0.00062	0.00592	CbGeAlD
Dinoprostone—SLC22A1—vagina—colon cancer	0.00059	0.00564	CbGeAlD
Dinoprostone—SLCO1B1—liver—colon cancer	0.000589	0.00563	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—colon cancer	0.000585	1	CrCbGaD
Dinoprostone—Acute coronary syndrome—Vincristine—colon cancer	0.000578	0.0073	CcSEcCtD
Dinoprostone—Myocardial infarction—Vincristine—colon cancer	0.000575	0.00726	CcSEcCtD
Dinoprostone—ABCC4—bone marrow—colon cancer	0.000571	0.00546	CbGeAlD
Dinoprostone—Musculoskeletal stiffness—Methotrexate—colon cancer	0.000567	0.00716	CcSEcCtD
Dinoprostone—SLCO3A1—lymph node—colon cancer	0.000564	0.00538	CbGeAlD
Dinoprostone—Skin discolouration—Methotrexate—colon cancer	0.000563	0.00711	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Irinotecan—colon cancer	0.000563	0.00711	CcSEcCtD
Dinoprostone—Myocardial infarction—Irinotecan—colon cancer	0.00056	0.00707	CcSEcCtD
Dinoprostone—SLCO2A1—lymph node—colon cancer	0.000558	0.00533	CbGeAlD
Dinoprostone—Deafness—Capecitabine—colon cancer	0.000555	0.007	CcSEcCtD
Dinoprostone—CYP11A1—lymph node—colon cancer	0.000552	0.00528	CbGeAlD
Dinoprostone—Eye pain—Capecitabine—colon cancer	0.00055	0.00694	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Fluorouracil—colon cancer	0.000539	0.00681	CcSEcCtD
Dinoprostone—Myocardial infarction—Fluorouracil—colon cancer	0.000536	0.00677	CcSEcCtD
Dinoprostone—Hot flush—Capecitabine—colon cancer	0.00053	0.0067	CcSEcCtD
Dinoprostone—Menopausal symptoms—Capecitabine—colon cancer	0.000526	0.00664	CcSEcCtD
Dinoprostone—Inflammation—Methotrexate—colon cancer	0.000525	0.00662	CcSEcCtD
Dinoprostone—SLCO2B1—liver—colon cancer	0.000521	0.00498	CbGeAlD
Dinoprostone—SLCO4A1—lymph node—colon cancer	0.000514	0.00491	CbGeAlD
Dinoprostone—CYP1A2—renal system—colon cancer	0.000513	0.0049	CbGeAlD
Dinoprostone—ABCC5—lymph node—colon cancer	0.000511	0.00488	CbGeAlD
Dinoprostone—Vaginal inflammation—Methotrexate—colon cancer	0.000509	0.00642	CcSEcCtD
Dinoprostone—SLC22A1—liver—colon cancer	0.000498	0.00476	CbGeAlD
Dinoprostone—Pharyngitis—Fluorouracil—colon cancer	0.000488	0.00616	CcSEcCtD
Dinoprostone—Vaginal infection—Methotrexate—colon cancer	0.00048	0.00607	CcSEcCtD
Dinoprostone—SLCO1A2—liver—colon cancer	0.00048	0.00458	CbGeAlD
Dinoprostone—Angiopathy—Vincristine—colon cancer	0.000478	0.00603	CcSEcCtD
Dinoprostone—Flushing—Irinotecan—colon cancer	0.000476	0.00601	CcSEcCtD
Dinoprostone—Cardiac arrest—Capecitabine—colon cancer	0.000472	0.00596	CcSEcCtD
Dinoprostone—Urinary retention—Capecitabine—colon cancer	0.000472	0.00596	CcSEcCtD
Dinoprostone—CYP19A1—liver—colon cancer	0.000468	0.00447	CbGeAlD
Dinoprostone—Angiopathy—Irinotecan—colon cancer	0.000465	0.00588	CcSEcCtD
Dinoprostone—Immune system disorder—Irinotecan—colon cancer	0.000463	0.00585	CcSEcCtD
Dinoprostone—ABCC4—liver—colon cancer	0.000462	0.00441	CbGeAlD
Dinoprostone—Dehydration—Capecitabine—colon cancer	0.000461	0.00583	CcSEcCtD
Dinoprostone—Chills—Irinotecan—colon cancer	0.00046	0.00581	CcSEcCtD
Dinoprostone—Arrhythmia—Irinotecan—colon cancer	0.000458	0.00578	CcSEcCtD
Dinoprostone—Back pain—Vincristine—colon cancer	0.000443	0.0056	CcSEcCtD
Dinoprostone—Arrhythmia—Fluorouracil—colon cancer	0.000439	0.00554	CcSEcCtD
Dinoprostone—Back pain—Irinotecan—colon cancer	0.000432	0.00545	CcSEcCtD
Dinoprostone—Muscle spasms—Irinotecan—colon cancer	0.000429	0.00542	CcSEcCtD
Dinoprostone—Asthma—Capecitabine—colon cancer	0.000429	0.00541	CcSEcCtD
Dinoprostone—Bronchospasm—Capecitabine—colon cancer	0.000422	0.00533	CcSEcCtD
Dinoprostone—CYP1A2—digestive system—colon cancer	0.000421	0.00402	CbGeAlD
Dinoprostone—Sweating increased—Capecitabine—colon cancer	0.000418	0.00527	CcSEcCtD
Dinoprostone—Vision blurred—Fluorouracil—colon cancer	0.000403	0.00509	CcSEcCtD
Dinoprostone—Syncope—Irinotecan—colon cancer	0.0004	0.00506	CcSEcCtD
Dinoprostone—SLCO2B1—lymph node—colon cancer	0.0004	0.00382	CbGeAlD
Dinoprostone—Hypertension—Vincristine—colon cancer	0.000396	0.005	CcSEcCtD
Dinoprostone—Loss of consciousness—Irinotecan—colon cancer	0.000392	0.00495	CcSEcCtD
Dinoprostone—Myalgia—Vincristine—colon cancer	0.00039	0.00493	CcSEcCtD
Dinoprostone—Cough—Irinotecan—colon cancer	0.00039	0.00492	CcSEcCtD
Dinoprostone—Hypertension—Irinotecan—colon cancer	0.000385	0.00487	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Methotrexate—colon cancer	0.000382	0.00482	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Capecitabine—colon cancer	0.000377	0.00476	CcSEcCtD
Dinoprostone—Myocardial infarction—Capecitabine—colon cancer	0.000375	0.00473	CcSEcCtD
Dinoprostone—Anaphylactic shock—Vincristine—colon cancer	0.000374	0.00472	CcSEcCtD
Dinoprostone—Anaphylactic shock—Irinotecan—colon cancer	0.000364	0.0046	CcSEcCtD
Dinoprostone—Myalgia—Fluorouracil—colon cancer	0.000364	0.0046	CcSEcCtD
Dinoprostone—Chest pain—Fluorouracil—colon cancer	0.000364	0.0046	CcSEcCtD
Dinoprostone—Hyperhidrosis—Vincristine—colon cancer	0.000362	0.00457	CcSEcCtD
Dinoprostone—CYP19A1—lymph node—colon cancer	0.000359	0.00343	CbGeAlD
Dinoprostone—Shock—Irinotecan—colon cancer	0.000358	0.00453	CcSEcCtD
Dinoprostone—ABCC4—lymph node—colon cancer	0.000354	0.00338	CbGeAlD
Dinoprostone—Hyperhidrosis—Irinotecan—colon cancer	0.000352	0.00445	CcSEcCtD
Dinoprostone—Hypotension—Vincristine—colon cancer	0.00035	0.00441	CcSEcCtD
Dinoprostone—Anaphylactic shock—Fluorouracil—colon cancer	0.000349	0.00441	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000341	0.0043	CcSEcCtD
Dinoprostone—Pharyngitis—Capecitabine—colon cancer	0.000341	0.0043	CcSEcCtD
Dinoprostone—Tachycardia—Fluorouracil—colon cancer	0.000341	0.0043	CcSEcCtD
Dinoprostone—Hypotension—Irinotecan—colon cancer	0.00034	0.0043	CcSEcCtD
Dinoprostone—Paraesthesia—Vincristine—colon cancer	0.000336	0.00424	CcSEcCtD
Dinoprostone—Paraesthesia—Irinotecan—colon cancer	0.000327	0.00413	CcSEcCtD
Dinoprostone—Hypotension—Fluorouracil—colon cancer	0.000326	0.00412	CcSEcCtD
Dinoprostone—Dyspnoea—Irinotecan—colon cancer	0.000325	0.0041	CcSEcCtD
Dinoprostone—Pain—Vincristine—colon cancer	0.00032	0.00404	CcSEcCtD
Dinoprostone—Asthma—Methotrexate—colon cancer	0.000319	0.00403	CcSEcCtD
Dinoprostone—Flushing—Capecitabine—colon cancer	0.000319	0.00402	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000318	0.00401	CcSEcCtD
Dinoprostone—CYP1A2—liver—colon cancer	0.000314	0.003	CbGeAlD
Dinoprostone—Paraesthesia—Fluorouracil—colon cancer	0.000313	0.00396	CcSEcCtD
Dinoprostone—Pain—Irinotecan—colon cancer	0.000312	0.00393	CcSEcCtD
Dinoprostone—Angiopathy—Capecitabine—colon cancer	0.000311	0.00393	CcSEcCtD
Dinoprostone—Dyspnoea—Fluorouracil—colon cancer	0.000311	0.00393	CcSEcCtD
Dinoprostone—Immune system disorder—Capecitabine—colon cancer	0.00031	0.00391	CcSEcCtD
Dinoprostone—Chills—Capecitabine—colon cancer	0.000308	0.00389	CcSEcCtD
Dinoprostone—Arrhythmia—Capecitabine—colon cancer	0.000307	0.00387	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Vincristine—colon cancer	0.000306	0.00386	CcSEcCtD
Dinoprostone—Pain—Fluorouracil—colon cancer	0.000298	0.00377	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Irinotecan—colon cancer	0.000298	0.00376	CcSEcCtD
Dinoprostone—Abdominal pain—Vincristine—colon cancer	0.000296	0.00373	CcSEcCtD
Dinoprostone—Body temperature increased—Vincristine—colon cancer	0.000296	0.00373	CcSEcCtD
Dinoprostone—Back pain—Capecitabine—colon cancer	0.000289	0.00365	CcSEcCtD
Dinoprostone—Abdominal pain—Irinotecan—colon cancer	0.000288	0.00364	CcSEcCtD
Dinoprostone—Body temperature increased—Irinotecan—colon cancer	0.000288	0.00364	CcSEcCtD
Dinoprostone—Muscle spasms—Capecitabine—colon cancer	0.000287	0.00363	CcSEcCtD
Dinoprostone—Vision blurred—Capecitabine—colon cancer	0.000282	0.00356	CcSEcCtD
Dinoprostone—Tremor—Capecitabine—colon cancer	0.00028	0.00353	CcSEcCtD
Dinoprostone—Body temperature increased—Fluorouracil—colon cancer	0.000276	0.00348	CcSEcCtD
Dinoprostone—Hypersensitivity—Vincristine—colon cancer	0.000276	0.00348	CcSEcCtD
Dinoprostone—Hypersensitivity—Irinotecan—colon cancer	0.000268	0.00339	CcSEcCtD
Dinoprostone—Asthenia—Vincristine—colon cancer	0.000268	0.00339	CcSEcCtD
Dinoprostone—Syncope—Capecitabine—colon cancer	0.000268	0.00338	CcSEcCtD
Dinoprostone—Loss of consciousness—Capecitabine—colon cancer	0.000263	0.00332	CcSEcCtD
Dinoprostone—Asthenia—Irinotecan—colon cancer	0.000261	0.0033	CcSEcCtD
Dinoprostone—Cough—Capecitabine—colon cancer	0.000261	0.00329	CcSEcCtD
Dinoprostone—Hypertension—Capecitabine—colon cancer	0.000258	0.00326	CcSEcCtD
Dinoprostone—Hypersensitivity—Fluorouracil—colon cancer	0.000257	0.00325	CcSEcCtD
Dinoprostone—Diarrhoea—Vincristine—colon cancer	0.000256	0.00323	CcSEcCtD
Dinoprostone—Arthralgia—Capecitabine—colon cancer	0.000254	0.00321	CcSEcCtD
Dinoprostone—Chest pain—Capecitabine—colon cancer	0.000254	0.00321	CcSEcCtD
Dinoprostone—Myalgia—Capecitabine—colon cancer	0.000254	0.00321	CcSEcCtD
Dinoprostone—Pharyngitis—Methotrexate—colon cancer	0.000254	0.0032	CcSEcCtD
Dinoprostone—Diarrhoea—Irinotecan—colon cancer	0.000249	0.00315	CcSEcCtD
Dinoprostone—Dizziness—Vincristine—colon cancer	0.000247	0.00312	CcSEcCtD
Dinoprostone—Dizziness—Irinotecan—colon cancer	0.000241	0.00304	CcSEcCtD
Dinoprostone—Shock—Capecitabine—colon cancer	0.00024	0.00303	CcSEcCtD
Dinoprostone—Diarrhoea—Fluorouracil—colon cancer	0.000239	0.00301	CcSEcCtD
Dinoprostone—Tachycardia—Capecitabine—colon cancer	0.000238	0.00301	CcSEcCtD
Dinoprostone—Vomiting—Vincristine—colon cancer	0.000238	0.003	CcSEcCtD
Dinoprostone—Rash—Vincristine—colon cancer	0.000236	0.00298	CcSEcCtD
Dinoprostone—Hyperhidrosis—Capecitabine—colon cancer	0.000236	0.00298	CcSEcCtD
Dinoprostone—Dermatitis—Vincristine—colon cancer	0.000236	0.00298	CcSEcCtD
Dinoprostone—Headache—Vincristine—colon cancer	0.000234	0.00296	CcSEcCtD
Dinoprostone—Angiopathy—Methotrexate—colon cancer	0.000232	0.00293	CcSEcCtD
Dinoprostone—Vomiting—Irinotecan—colon cancer	0.000232	0.00293	CcSEcCtD
Dinoprostone—Immune system disorder—Methotrexate—colon cancer	0.000231	0.00291	CcSEcCtD
Dinoprostone—Dizziness—Fluorouracil—colon cancer	0.000231	0.00291	CcSEcCtD
Dinoprostone—Rash—Irinotecan—colon cancer	0.00023	0.0029	CcSEcCtD
Dinoprostone—Dermatitis—Irinotecan—colon cancer	0.00023	0.0029	CcSEcCtD
Dinoprostone—Chills—Methotrexate—colon cancer	0.000229	0.00289	CcSEcCtD
Dinoprostone—Headache—Irinotecan—colon cancer	0.000228	0.00288	CcSEcCtD
Dinoprostone—Hypotension—Capecitabine—colon cancer	0.000228	0.00288	CcSEcCtD
Dinoprostone—Nausea—Vincristine—colon cancer	0.000222	0.00281	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000222	0.00281	CcSEcCtD
Dinoprostone—Vomiting—Fluorouracil—colon cancer	0.000222	0.0028	CcSEcCtD
Dinoprostone—Rash—Fluorouracil—colon cancer	0.00022	0.00278	CcSEcCtD
Dinoprostone—Dermatitis—Fluorouracil—colon cancer	0.00022	0.00278	CcSEcCtD
Dinoprostone—Paraesthesia—Capecitabine—colon cancer	0.000219	0.00276	CcSEcCtD
Dinoprostone—Headache—Fluorouracil—colon cancer	0.000219	0.00276	CcSEcCtD
Dinoprostone—Dyspnoea—Capecitabine—colon cancer	0.000217	0.00275	CcSEcCtD
Dinoprostone—Nausea—Irinotecan—colon cancer	0.000216	0.00273	CcSEcCtD
Dinoprostone—Back pain—Methotrexate—colon cancer	0.000215	0.00272	CcSEcCtD
Dinoprostone—Vision blurred—Methotrexate—colon cancer	0.00021	0.00265	CcSEcCtD
Dinoprostone—Pain—Capecitabine—colon cancer	0.000209	0.00263	CcSEcCtD
Dinoprostone—Nausea—Fluorouracil—colon cancer	0.000207	0.00262	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Capecitabine—colon cancer	0.000199	0.00252	CcSEcCtD
Dinoprostone—Cough—Methotrexate—colon cancer	0.000194	0.00245	CcSEcCtD
Dinoprostone—Abdominal pain—Capecitabine—colon cancer	0.000193	0.00243	CcSEcCtD
Dinoprostone—Body temperature increased—Capecitabine—colon cancer	0.000193	0.00243	CcSEcCtD
Dinoprostone—Arthralgia—Methotrexate—colon cancer	0.000189	0.00239	CcSEcCtD
Dinoprostone—Chest pain—Methotrexate—colon cancer	0.000189	0.00239	CcSEcCtD
Dinoprostone—Myalgia—Methotrexate—colon cancer	0.000189	0.00239	CcSEcCtD
Dinoprostone—Anaphylactic shock—Methotrexate—colon cancer	0.000182	0.00229	CcSEcCtD
Dinoprostone—Hypersensitivity—Capecitabine—colon cancer	0.00018	0.00227	CcSEcCtD
Dinoprostone—Hyperhidrosis—Methotrexate—colon cancer	0.000176	0.00222	CcSEcCtD
Dinoprostone—Asthenia—Capecitabine—colon cancer	0.000175	0.00221	CcSEcCtD
Dinoprostone—Hypotension—Methotrexate—colon cancer	0.00017	0.00214	CcSEcCtD
Dinoprostone—Diarrhoea—Capecitabine—colon cancer	0.000167	0.00211	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000165	0.00209	CcSEcCtD
Dinoprostone—Paraesthesia—Methotrexate—colon cancer	0.000163	0.00206	CcSEcCtD
Dinoprostone—Dyspnoea—Methotrexate—colon cancer	0.000162	0.00204	CcSEcCtD
Dinoprostone—Dizziness—Capecitabine—colon cancer	0.000161	0.00204	CcSEcCtD
Dinoprostone—Pain—Methotrexate—colon cancer	0.000155	0.00196	CcSEcCtD
Dinoprostone—Vomiting—Capecitabine—colon cancer	0.000155	0.00196	CcSEcCtD
Dinoprostone—Rash—Capecitabine—colon cancer	0.000154	0.00194	CcSEcCtD
Dinoprostone—Dermatitis—Capecitabine—colon cancer	0.000154	0.00194	CcSEcCtD
Dinoprostone—Headache—Capecitabine—colon cancer	0.000153	0.00193	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Methotrexate—colon cancer	0.000148	0.00187	CcSEcCtD
Dinoprostone—Nausea—Capecitabine—colon cancer	0.000145	0.00183	CcSEcCtD
Dinoprostone—Body temperature increased—Methotrexate—colon cancer	0.000144	0.00181	CcSEcCtD
Dinoprostone—Abdominal pain—Methotrexate—colon cancer	0.000144	0.00181	CcSEcCtD
Dinoprostone—Hypersensitivity—Methotrexate—colon cancer	0.000134	0.00169	CcSEcCtD
Dinoprostone—Asthenia—Methotrexate—colon cancer	0.00013	0.00164	CcSEcCtD
Dinoprostone—Diarrhoea—Methotrexate—colon cancer	0.000124	0.00157	CcSEcCtD
Dinoprostone—Dizziness—Methotrexate—colon cancer	0.00012	0.00152	CcSEcCtD
Dinoprostone—Vomiting—Methotrexate—colon cancer	0.000115	0.00146	CcSEcCtD
Dinoprostone—Rash—Methotrexate—colon cancer	0.000114	0.00145	CcSEcCtD
Dinoprostone—Dermatitis—Methotrexate—colon cancer	0.000114	0.00144	CcSEcCtD
Dinoprostone—Headache—Methotrexate—colon cancer	0.000114	0.00144	CcSEcCtD
Dinoprostone—Nausea—Methotrexate—colon cancer	0.000108	0.00136	CcSEcCtD
Dinoprostone—PTGER3—Signaling Pathways—BRAF—colon cancer	2.62e-05	0.000435	CbGpPWpGaD
Dinoprostone—PTGER4—GPCR downstream signaling—AKT1—colon cancer	2.62e-05	0.000434	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.61e-05	0.000432	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—HRAS—colon cancer	2.6e-05	0.000432	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—KRAS—colon cancer	2.6e-05	0.000431	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CASP3—colon cancer	2.59e-05	0.00043	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—EP300—colon cancer	2.56e-05	0.000425	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ABCB1—colon cancer	2.55e-05	0.000423	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—EGFR—colon cancer	2.54e-05	0.000421	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CCND1—colon cancer	2.52e-05	0.000419	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—APC—colon cancer	2.51e-05	0.000416	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—TYMS—colon cancer	2.51e-05	0.000415	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CTNNB1—colon cancer	2.5e-05	0.000415	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.5e-05	0.000414	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CDKN1A—colon cancer	2.44e-05	0.000405	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—PIK3CA—colon cancer	2.43e-05	0.000403	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ODC1—colon cancer	2.42e-05	0.000401	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CHST5—colon cancer	2.42e-05	0.000401	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—KRAS—colon cancer	2.4e-05	0.000398	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—PIK3CA—colon cancer	2.39e-05	0.000396	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—AKT1—colon cancer	2.38e-05	0.000394	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	2.37e-05	0.000392	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—BRAF—colon cancer	2.36e-05	0.000391	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—EP300—colon cancer	2.32e-05	0.000385	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—AKT1—colon cancer	2.3e-05	0.000381	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.3e-05	0.000381	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—FGFR3—colon cancer	2.27e-05	0.000377	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—EP300—colon cancer	2.27e-05	0.000376	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SRC—colon cancer	2.26e-05	0.000375	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—FGFR3—colon cancer	2.22e-05	0.000369	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—FGFR3—colon cancer	2.22e-05	0.000369	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—HRAS—colon cancer	2.21e-05	0.000367	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—PIK3CA—colon cancer	2.21e-05	0.000366	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—HRAS—colon cancer	2.2e-05	0.000366	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—SRC—colon cancer	2.2e-05	0.000366	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—VEGFA—colon cancer	2.2e-05	0.000365	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—NRAS—colon cancer	2.17e-05	0.000361	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—AKT1—colon cancer	2.15e-05	0.000357	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VEGFA—colon cancer	2.15e-05	0.000356	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CASP3—colon cancer	2.13e-05	0.000353	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—NRAS—colon cancer	2.12e-05	0.000352	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—APC—colon cancer	2.09e-05	0.000346	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—NRAS—colon cancer	2.09e-05	0.000346	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.08e-05	0.000344	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CCND1—colon cancer	2.07e-05	0.000344	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CTNNB1—colon cancer	2.05e-05	0.00034	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—APC—colon cancer	2.04e-05	0.000339	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—APC—colon cancer	2.04e-05	0.000339	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—NRAS—colon cancer	2.04e-05	0.000339	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—NRAS—colon cancer	2.04e-05	0.000339	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—HRAS—colon cancer	2.04e-05	0.000338	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PPARG—colon cancer	2.03e-05	0.000336	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MYC—colon cancer	2.02e-05	0.000336	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFB1—colon cancer	2.02e-05	0.000335	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CDKN1A—colon cancer	2.01e-05	0.000333	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—AKT1—colon cancer	1.98e-05	0.000329	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—EGFR—colon cancer	1.98e-05	0.000328	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TGFB1—colon cancer	1.97e-05	0.000327	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CASP3—colon cancer	1.97e-05	0.000326	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.96e-05	0.000326	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—BRAF—colon cancer	1.96e-05	0.000325	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—AKT1—colon cancer	1.95e-05	0.000324	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.93e-05	0.00032	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—BRAF—colon cancer	1.92e-05	0.000318	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—BRAF—colon cancer	1.92e-05	0.000318	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CCND1—colon cancer	1.91e-05	0.000317	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.91e-05	0.000317	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EP300—colon cancer	1.91e-05	0.000316	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTGS2—colon cancer	1.9e-05	0.000316	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—EGFR—colon cancer	1.9e-05	0.000315	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CTNNB1—colon cancer	1.89e-05	0.000314	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PIK3CA—colon cancer	1.89e-05	0.000314	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—KRAS—colon cancer	1.87e-05	0.00031	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ABCB1—colon cancer	1.87e-05	0.00031	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—EGFR—colon cancer	1.86e-05	0.000308	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—EGFR—colon cancer	1.86e-05	0.000308	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SRC—colon cancer	1.86e-05	0.000308	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CDKN1A—colon cancer	1.85e-05	0.000307	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—TYMS—colon cancer	1.84e-05	0.000305	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—KRAS—colon cancer	1.82e-05	0.000303	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—PIK3CA—colon cancer	1.82e-05	0.000301	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—HRAS—colon cancer	1.81e-05	0.000301	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—colon cancer	1.81e-05	0.0003	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—AKT1—colon cancer	1.8e-05	0.000299	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—KRAS—colon cancer	1.79e-05	0.000298	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—NRAS—colon cancer	1.79e-05	0.000296	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—PIK3CA—colon cancer	1.78e-05	0.000295	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—PIK3CA—colon cancer	1.78e-05	0.000295	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PPARG—colon cancer	1.77e-05	0.000294	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EP300—colon cancer	1.76e-05	0.000292	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—KRAS—colon cancer	1.76e-05	0.000291	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—KRAS—colon cancer	1.76e-05	0.000291	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.73e-05	0.000286	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PIK3CA—colon cancer	1.72e-05	0.000285	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SRC—colon cancer	1.71e-05	0.000284	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CTNNB1—colon cancer	1.7e-05	0.000282	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ABCB1—colon cancer	1.69e-05	0.00028	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—HRAS—colon cancer	1.69e-05	0.00028	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PIK3CA—colon cancer	1.68e-05	0.000278	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—colon cancer	1.67e-05	0.000277	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CDKN1A—colon cancer	1.66e-05	0.000276	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—colon cancer	1.66e-05	0.000276	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—colon cancer	1.66e-05	0.000276	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—TYMS—colon cancer	1.66e-05	0.000275	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—colon cancer	1.66e-05	0.000275	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—PIK3CA—colon cancer	1.65e-05	0.000274	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NRAS—colon cancer	1.65e-05	0.000273	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.63e-05	0.000271	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EGFR—colon cancer	1.63e-05	0.00027	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—colon cancer	1.62e-05	0.000269	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—PIK3CA—colon cancer	1.61e-05	0.000268	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—PIK3CA—colon cancer	1.61e-05	0.000268	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ABCB1—colon cancer	1.6e-05	0.000265	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—colon cancer	1.59e-05	0.000264	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HRAS—colon cancer	1.59e-05	0.000264	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EP300—colon cancer	1.58e-05	0.000263	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—TYMS—colon cancer	1.57e-05	0.00026	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HRAS—colon cancer	1.55e-05	0.000257	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—AKT1—colon cancer	1.55e-05	0.000257	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SRC—colon cancer	1.54e-05	0.000255	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KRAS—colon cancer	1.54e-05	0.000255	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—colon cancer	1.53e-05	0.000255	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—colon cancer	1.53e-05	0.000254	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—colon cancer	1.53e-05	0.000253	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—colon cancer	1.5e-05	0.000249	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—colon cancer	1.49e-05	0.000248	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—colon cancer	1.49e-05	0.000248	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—colon cancer	1.48e-05	0.000246	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NRAS—colon cancer	1.48e-05	0.000246	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CASP3—colon cancer	1.47e-05	0.000244	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ABCB1—colon cancer	1.46e-05	0.000243	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—colon cancer	1.45e-05	0.000241	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—colon cancer	1.45e-05	0.000241	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—TYMS—colon cancer	1.44e-05	0.000239	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP3—colon cancer	1.44e-05	0.000239	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP3—colon cancer	1.44e-05	0.000239	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—colon cancer	1.43e-05	0.000237	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—colon cancer	1.42e-05	0.000235	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CTNNB1—colon cancer	1.42e-05	0.000235	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.41e-05	0.000234	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CA—colon cancer	1.41e-05	0.000234	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—colon cancer	1.4e-05	0.000233	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—colon cancer	1.4e-05	0.000232	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—colon cancer	1.4e-05	0.000232	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—colon cancer	1.4e-05	0.000232	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CTNNB1—colon cancer	1.39e-05	0.00023	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CTNNB1—colon cancer	1.39e-05	0.00023	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1A—colon cancer	1.38e-05	0.00023	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—colon cancer	1.38e-05	0.000229	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—colon cancer	1.38e-05	0.000228	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—colon cancer	1.37e-05	0.000227	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—colon cancer	1.37e-05	0.000226	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ABCB1—colon cancer	1.37e-05	0.000226	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1A—colon cancer	1.35e-05	0.000225	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1A—colon cancer	1.35e-05	0.000225	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—colon cancer	1.35e-05	0.000224	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—colon cancer	1.35e-05	0.000223	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—TYMS—colon cancer	1.34e-05	0.000222	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—EP300—colon cancer	1.33e-05	0.00022	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—colon cancer	1.32e-05	0.000219	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—colon cancer	1.32e-05	0.000219	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EP300—colon cancer	1.32e-05	0.000218	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—colon cancer	1.31e-05	0.000217	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CA—colon cancer	1.3e-05	0.000216	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARG—colon cancer	1.3e-05	0.000216	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EP300—colon cancer	1.29e-05	0.000214	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EP300—colon cancer	1.29e-05	0.000214	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SRC—colon cancer	1.28e-05	0.000212	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.28e-05	0.000212	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—colon cancer	1.27e-05	0.000211	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—colon cancer	1.26e-05	0.000209	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SRC—colon cancer	1.25e-05	0.000208	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SRC—colon cancer	1.25e-05	0.000208	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—colon cancer	1.25e-05	0.000207	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NRAS—colon cancer	1.23e-05	0.000204	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—colon cancer	1.22e-05	0.000202	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—colon cancer	1.22e-05	0.000202	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.21e-05	0.0002	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NRAS—colon cancer	1.21e-05	0.0002	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NRAS—colon cancer	1.21e-05	0.0002	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—colon cancer	1.21e-05	0.0002	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARG—colon cancer	1.18e-05	0.000195	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PIK3CA—colon cancer	1.17e-05	0.000194	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—EP300—colon cancer	1.16e-05	0.000193	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—colon cancer	1.15e-05	0.000191	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—colon cancer	1.15e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—colon cancer	1.14e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—colon cancer	1.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—colon cancer	1.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—colon cancer	1.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—colon cancer	1.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—colon cancer	1.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARG—colon cancer	1.11e-05	0.000184	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—colon cancer	1.1e-05	0.000182	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—colon cancer	1.1e-05	0.000182	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—colon cancer	1.08e-05	0.00018	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—colon cancer	1.06e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—colon cancer	1.06e-05	0.000176	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—colon cancer	1.04e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—colon cancer	1.04e-05	0.000172	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—colon cancer	1.02e-05	0.00017	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARG—colon cancer	1.02e-05	0.000169	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.98e-06	0.000166	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CA—colon cancer	9.81e-06	0.000163	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CA—colon cancer	9.74e-06	0.000162	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—colon cancer	9.57e-06	0.000159	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CA—colon cancer	9.54e-06	0.000158	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CA—colon cancer	9.54e-06	0.000158	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARG—colon cancer	9.5e-06	0.000158	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—colon cancer	9.42e-06	0.000156	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—colon cancer	9.25e-06	0.000153	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—colon cancer	9.22e-06	0.000153	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—colon cancer	9.22e-06	0.000153	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—colon cancer	9.01e-06	0.000149	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—colon cancer	8.82e-06	0.000146	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—colon cancer	8.82e-06	0.000146	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—colon cancer	8.75e-06	0.000145	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CA—colon cancer	8.59e-06	0.000142	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—EP300—colon cancer	8.51e-06	0.000141	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—colon cancer	8.02e-06	0.000133	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—colon cancer	8.01e-06	0.000133	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—colon cancer	7.96e-06	0.000132	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.85e-06	0.00013	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—colon cancer	7.79e-06	0.000129	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—colon cancer	7.79e-06	0.000129	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—EP300—colon cancer	7.69e-06	0.000128	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—colon cancer	7.47e-06	0.000124	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—EP300—colon cancer	7.28e-06	0.000121	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—colon cancer	7.02e-06	0.000116	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—EP300—colon cancer	6.67e-06	0.000111	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.53e-06	0.000108	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCB1—colon cancer	6.39e-06	0.000106	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CA—colon cancer	6.29e-06	0.000104	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TYMS—colon cancer	6.27e-06	0.000104	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—EP300—colon cancer	6.22e-06	0.000103	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CA—colon cancer	5.69e-06	9.44e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CA—colon cancer	5.38e-06	8.93e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—colon cancer	5.14e-06	8.53e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CA—colon cancer	4.93e-06	8.18e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.83e-06	8.01e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—colon cancer	4.65e-06	7.71e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CA—colon cancer	4.6e-06	7.63e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARG—colon cancer	4.45e-06	7.37e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—colon cancer	4.4e-06	7.29e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—colon cancer	4.03e-06	6.68e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—colon cancer	3.76e-06	6.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—colon cancer	3.5e-06	5.8e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—EP300—colon cancer	2.91e-06	4.82e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CA—colon cancer	2.15e-06	3.57e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—colon cancer	1.76e-06	2.91e-05	CbGpPWpGaD
